The estimated Net Worth of Wayne S De Veydt is at least $35.2 Million dollars as of 19 December 2023. Mr. Veydt owns over 168,130 units of Surgery Partners Inc stock worth over $4,015,442 and over the last 10 years he sold SGRY stock worth over $27,596,595. In addition, he makes $3,631,240 as Executive Chairman of the Board at Surgery Partners Inc.
Wayne has made over 7 trades of the Surgery Partners Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 168,130 units of SGRY stock worth $5,622,267 on 19 December 2023.
The largest trade he's ever made was selling 168,130 units of Surgery Partners Inc stock on 19 December 2023 worth over $5,622,267. On average, Wayne trades about 7,720 units every 69 days since 2014. As of 19 December 2023 he still owns at least 131,870 units of Surgery Partners Inc stock.
You can see the complete history of Mr. Veydt stock trades at the bottom of the page.
Wayne S. DeVeydt serves as Executive Chairman of the Board of the Company. Mr. DeVeydt currently is Executive Chairman of Surgery Partners, a role he has held since January 2020 and previously served as Chief Executive Officer of Surgery Partners from January 2018 until January 2020. From January 2017 until January 2018, Mr. DeVeydt served as a Senior Advisor to the Global Healthcare division of Bain Capital Private Equity, LP, the investment advisor of BCPE Seminole Holdings LP, the Company's controlling stockholder. From May 2007 to May 2016, Mr. DeVeydt served as Executive Vice President and Chief Financial Officer of Anthem, Inc., a health insurance company. From March 2005 to May 2007, he served as Anthem's Senior Vice President and Chief Accounting Officer and for a portion of that time, he also served as Chief of Staff to the Chairman and Chief Executive Officer. Prior to joining Anthem, Mr. DeVeydt served as a partner at PricewaterhouseCoopers LLP, focused on companies in the national managed care and insurance industries. Since March 2016, Mr. DeVeydt has served as a director of NiSource Inc., a utilities company. Mr. DeVeydt previously served on the board of directors of Grupo Notre Dame Intermedica and as a director of Myovant Sciences Ltd, a biopharmaceutical company. Mr. DeVeydt received his B.S. in Business Administration from the University of Missouri in St. Louis. Our Board believes that Mr. DeVeydt is qualified to serve as a director based on his service as our Chief Executive Officer and his prior experience serving as an executive in the healthcare industry.
As the Executive Chairman of the Board of Surgery Partners Inc, the total compensation of Wayne DeVeydt at Surgery Partners Inc is $3,631,240. There are 1 executives at Surgery Partners Inc getting paid more, with J. Eric Evans having the highest compensation of $4,644,930.
Wayne DeVeydt is 50, he's been the Executive Chairman of the Board of Surgery Partners Inc since 2020. There are 11 older and 7 younger executives at Surgery Partners Inc. The oldest executive at Surgery Partners Inc is Clifford Adlerz, 66, who is the Director.
Wayne's mailing address filed with the SEC is 7700 FORSYTH BOULEVARD, , ST. LOUIS, MO, 63105.
Over the last 9 years, insiders at Surgery Partners Inc have traded over $1,643,866,633 worth of Surgery Partners Inc stock and bought 83,000 units worth $1,133,800 . The most active insiders traders include T. Devin O'reilly, Surgery Centers, Llchig Gp ..., and Capital Investors Llcbcpe S.... On average, Surgery Partners Inc executives and independent directors trade stock every 26 days with the average trade being worth of $26,258,040. The most recent stock trade was executed by Harrison R. Bane on 1 September 2024, trading 6,325 units of SGRY stock currently worth $196,771.
surgery partners is a leading operator of surgical facilities and ancillary services with more than 180 locations nationwide. we provide exceptional integrated healthcare experiences between our providers and patients. our diverse company operates multiple types of healthcare services dedicated to improving the quality of care in a convenient and cost-effective manner. the support of our ancillary services is one of many unique attributes that differentiate us from our competitors. these services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, optical services and specialty pharmacy services. our integrated approach to advancing markets allows for flexibility to provide care on an individualized, local market basis. whether entering into a new market with surgical facilities, ancillary services or joint ventures with health systems, or furthering an existing market’s growth potential by focusing on base busines
Surgery Partners Inc executives and other stock owners filed with the SEC include: